Pharmacogenomic predictor of long-term residual chemotherapy-induced peripheral neuropathy in ovarian cancer…

Topical herbal medicine as treatment for chemotherapy-induced peripheral neuropathy: a systematic review of randomized controlled trials
Carrie Shao, Cassie Shao, Andrew Haggarty +2
Frontiers in oncology16 Oct 2026Peer-reviewedCC BYFull textOncologyEurope PMC
Selected Ion Channels in Chemotherapy-Induced Peripheral Neuropathy: Mechanisms and Translational Limits
Xunlang Zhang, Dekun Liu, Mingkai Yu +7
Biomolecules15 Oct 2026Peer-reviewedCC BY 4.0OncologyCrossref
miR-378f targets CAB39 to regulate autophagy in chemotherapy-induced peripheral neuropathy.
Yeeun Kim, Myeongguk Jeong, Hyeokjin Kwon +5
Frontiers in molecular neuroscience7 Oct 2026Peer-reviewedCC BYFull textOncologyEurope PMC
Baseline Peripheral Neuropathy Predicts Clinically Significant Neuropathy During Paclitaxel Treatment Following Oxaliplatin-based Chemotherapy.
Aiko Tomiuchi, Michio Kimura, Yoshiaki Ikeda +1
Cancer diagnosis & prognosis1 Nov 2026Peer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
Effect of cryotherapy on chemotherapy-induced peripheral neuropathy in patients with breast cancer treated with taxanes: a systematic review using the GRADE system.
Rikke Elgaard Gravesen, Maria Elisabeth Lendorf, Hatice Tankisi +1
BMJ neurology open15 Oct 2026Peer-reviewedCC BY-NCFull textOncologyEurope PMC

Cite

BibTeX

@article{zenatri2026pharmacogenomic,
  title = {{Pharmacogenomic predictor of long-term residual chemotherapy-induced peripheral neuropathy in ovarian cancer survivors: A substudy of the GINECO Vivrovaire study}},
  author = {M. Zenatri and T. Perennec and C. Michon and F. Gernier and J.-M. Grellard and F.-X. Piloquet and C. Dubot-Poitelon and E. Kalbacher and O. Tredan and P. Augereau and P. Pautier and L. Fey and F. Joly and J.-S. Frenel},
  journal = {Gynecologic Oncology},
  year = {2026},
  month = sep,
  doi = {10.1016/j.ygyno.2024.04.021},
  url = {https://hal.science/hal-05741130v1},
}

RIS

TY  - JOUR
TI  - Pharmacogenomic predictor of long-term residual chemotherapy-induced peripheral neuropathy in ovarian cancer survivors: A substudy of the GINECO Vivrovaire study
AU  - M. Zenatri
AU  - T. Perennec
AU  - C. Michon
AU  - F. Gernier
AU  - J.-M. Grellard
AU  - F.-X. Piloquet
AU  - C. Dubot-Poitelon
AU  - E. Kalbacher
AU  - O. Tredan
AU  - P. Augereau
AU  - P. Pautier
AU  - L. Fey
AU  - F. Joly
AU  - J.-S. Frenel
PY  - 2026
DA  - 2026/09/07
JO  - Gynecologic Oncology
DO  - 10.1016/j.ygyno.2024.04.021
UR  - https://hal.science/hal-05741130v1
SN  - 0090-8258
SN  - 1095-6859
ER  -

Related

Cite